Corvus Pharmaceuticals (CRVS) Other Working Capital Changes (2015 - 2026)
Corvus Pharmaceuticals (CRVS) recorded quarterly Other Working Capital Changes of $865000.0 in Q1 2026, up 324.02% quarter-over-quarter from $204000.0 in Q4 2025, and up 174.06% on a YoY basis from $315626.4 in Q1 2025.
Corvus Pharmaceuticals (CRVS) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Other Working Capital Changes history runs 12 years deep, the most recent figure standing at $865000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 174.06% year-over-year to $865000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 475.26% YoY), while the FY2025 annual figure was -$941000.0, down 273.3% from the prior year.
- Other Working Capital Changes was $865000.0 for Q1 2026 at Corvus Pharmaceuticals, up from $204000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.1 million in Q2 2025 to a low of -$1.2 million in Q1 2025.
- Historically, Other Working Capital Changes has averaged $21647.1 across 5 years, with a median of $204000.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes sank 343.18% in 2023, then surged 691.67% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$884000.0 in 2022, then surged by 105.43% to $48000.0 in 2023, then soared by 691.67% to $380000.0 in 2024, then plunged by 46.32% to $204000.0 in 2025, then soared by 324.02% to $865000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $865000.0 (Q1 2026), $204000.0 (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Corvus Pharmaceuticals | 1.00 Bn | 766.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 865,000.00 |
| Mar 31, 2026 | 865,000.00 |
| Dec 31, 2025 | 204,000.00 |
| Dec 31, 2025 | 204,000.00 |
| Sep 30, 2025 | -1.11 Mn |
| Sep 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | 380,000.00 |
| Dec 31, 2024 | 380,000.00 |
| Sep 30, 2024 | 837,000.00 |
| Sep 30, 2024 | 837,000.00 |
| Jun 30, 2024 | -340,000.00 |
| Jun 30, 2024 | -340,000.00 |
| Mar 31, 2024 | -334,000.00 |
| Mar 31, 2024 | -334,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Dec 31, 2023 | 48,000.00 |